PrairieSky Royalty: Record Oil Volumes Boost Dividendby Mark Eisenberg 13.02.2024PrairieSky Royalty reports strong Q4 and year-end results, achieving record oil royalty production and increasing annual dividend by 4%. Analysts ...
Ohio Law on Social Media Use Blocked by Federal Judgeby Lilu Anderson 13.02.2024A federal judge has blocked an Ohio law requiring parental consent for children under 16 to use social media platforms. ...
Amazon Faces Lawsuit Over ‘Buy Box’ Deceptionby Mark Eisenberg 13.02.2024Amazon is facing a lawsuit alleging that it tricks customers into purchasing more expensive products through its Buy Box feature. ...
Valentine’s Day Strike: Drivers Fight for Fair Payby Lilu Anderson 13.02.2024Uber, Lyft, and DoorDash drivers are planning a nationwide strike on Valentine's Day to demand fair pay. This comes after ...
Crypto 2024 Forecast: Top 5 Altcoins to Watchby John Darbie 13.02.2024Industry experts predict bullish trends in the crypto market due to the upcoming halving event for Bitcoin and the approval ...
Top Stocks Beat S&P 500: Unlock Wealth with ROICby Mark Eisenberg 12.02.2024Investing in companies with high ROICs can potentially lead to better returns than index funds. Consider the long-term financial performance ...
Uber, Lyft Drivers Strike Demanding Fair Payby Mark Eisenberg 12.02.2024Ride-share and food delivery drivers in the US are set to strike on Valentine's Day, demanding fair pay from Uber, ...
Revolutionizing Workplaces with Equitable Language: Boost Productivity & Inclusivityby Lilu Anderson 12.02.2024Language plays a critical role in driving positive change in the workplace. Companies like Salesforce and Workday are implementing inclusive ...
Rail Vision’s Revolutionary AI Enhancing Railway Safetyby Lilu Anderson 12.02.2024Rail Vision has unveiled its next-generation AI-based computer, aimed at enhancing railway safety and preventing accidents by detecting potential hazards. ...
Tonix Pharma’s Potential PTSD Cure: A Game-Changer?by Mark Eisenberg 12.02.2024Tonix Pharmaceuticals receives FDA clearance for its OASIS trial, evaluating the efficacy of TNX-102 SL in treating acute stress reactions ...